tm logo
TAQTEF
Live/Registered
REGISTERED

on 15 Feb 2022

Last Applicant/ Owned by

Viaduktstrasse 8

Basel

CH

4051

Serial Number

90401644 filed on 22nd Dec 2020

Registration Number

6642761 registered on 15th Feb 2022

in the Principal Register

Correspondent Address

Allison Strickland Ricketts

FROSS ZELNICK LEHRMAN & ZISSU, P.C.

151 WEST 42ND STREET, 17TH FLOOR

NEW YORK, NY 10036

Filing Basis

No Filing Basis

Disclaimer

NO DATA

TAQTEF

Pharmaceutical preparations for human use for the treatment of dermatitis and acne; biologic preparations for medical and therapeutic purposes for the treatment of dermatitis and acne; pharmaceutical preparations and biologic preparations for the treatment of skin diseases and disorders; pharmaceutical preparations and biologic preparations for the treatment of psoriasis and atopic dermatitis

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for human use for the treatment of dermatitis and acne; biologic preparations for medical and therapeutic purposes for the treatment of dermatitis and acne; pharmaceutical preparations and biologic preparations for the treatment of skin diseases and disorders; pharmaceutical preparations and biologic preparations for the treatment of psoriasis and atopic dermatitis

Mark Details


Serial Number

No 90401644

Mark Type

No Service/Collective Mark

Attorney Docket Number

No DERM 2008871

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
15th Feb 2022REGISTERED-PRINCIPAL REGISTER
30th Nov 2021PUBLISHED FOR OPPOSITION
30th Nov 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10th Nov 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27th Oct 2021ELECTRONIC RECORD REVIEW COMPLETE
22nd Oct 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
18th Oct 2021APPROVED FOR PUB - PRINCIPAL REGISTER
28th Aug 2021TEAS/EMAIL CORRESPONDENCE ENTERED
27th Aug 2021NON-FINAL ACTION WRITTEN
27th Aug 2021NON-FINAL ACTION E-MAILED